I-Inlexisertib;DCC-3116
Iinkcukacha zeMveliso
Iithegi zeMveliso
Ubungakanani bePakethe | Ubukho | Ixabiso (USD) |
Igama leMchiza:
4-(3-((2-((2-ethyl-4-(4-methylpiperazin-1-yl)phenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)propyl)-1,4 -oxazepan-5-enye
Ikhowudi yoncumo:
O=C1CCOCCN1CCCNC2=NC(NC3=C(CC)C=C(N4CCN(C)CC4)C=C3)=NC=C2C(F)(F)F
Ikhowudi ye-InChi:
InChI=1S/C26H36F3N7O2/c1-3-19-17-20(35-12-10-34(2)11-13-35)5-6-22(19)32-25-31-18-21( 26(27,28 )29)24(33-25)30-8-4-9-36-14-16-38-15-7-23(36)37/h5-6,17-18H,3-4,7-16H2 ,1-2H3,(H2,30,31,32,33)
Isitshixo se-InChi:
CNBTYICEJGEABG-UHFFFAOYSA-N
Igama elingundoqo:
2543673-19-2;CAS:2543673-19-2;CAS:2543673-19-2;DCC3116;DCC-3116;DCC 3116;Inlexisertib
Ukunyibilika:
Ugcino:Yomile, emnyama kunye ne-0 -4 C kwixesha elifutshane (iintsuku ukuya kwiiveki) okanye -20 C ixesha elide (iinyanga ukuya kwiminyaka).
Inkcazo:
I-DCC-3116 yi-ULK1/2 inhibitor esebenzayo ngomlomo.
Ithagethi: ULK1/2